Multiple broad-spectrum Beta-lactamase targets for comprehensive surveillance.
Real-time PCR testing for blaKPC, blaNDM, blaVIM, blaIMP, and blaCTX-M was performed on rectal swabs obtained from residents of two long-term acute-care facilities. While blaKPC was detected in 69/102 swabs (67.6%), testing for four other targets increased the positivity rate for a broad-spectrum β-lactamase to 73.5% (McNemar's P = 0.03).
Pathology, NorthShore University HealthSystem, Evanston, Illinois, USA.
Kathy A
KA
Mangold
Barbara L
BL
Voss
Kamaljit
K
Singh
Richard B
RB
Thomson
Donna M
DM
Schora
Lance R
LR
Peterson
Karen L
KL
Kaul
D001003:Anal Canal / Q000382:microbiology*; D001419:Bacteria / Q000201:enzymology* / Q000235:genetics; D062665:Epidemiological Monitoring; D006801:Humans; D008134:Long-Term Care; D015995:Prevalence; D060888:Real-Time Polymerase Chain Reaction / Q000379:methods*; D001618:beta-Lactamases / Q000235:genetics*
D001618:beta-Lactamases